Amends TCA Title 53, Chapter 11.
Tennessee SB1848 authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without naloxone. The bill affects healthcare providers involved in the treatment of opioid use disorder, specifically allowing them to prescribe buprenorphine products to nursing mothers and injectable mono products without restrictions related to naloxone. Key provisions include the expansion of prescribing authority for certain healthcare providers regarding buprenorphine treatment.
Tennessee SB1848 authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without naloxone. The bill affects healthcare providers involved in the treatment of opioid use disorder, specifically allowing them to prescribe buprenorphine products to nursing mothers and injectable mono products without restrictions related to naloxone. Key provisions include the expansion of prescribing authority for certain healthcare providers regarding buprenorphine treatment.
Track Tennessee Legislation Like a Pro
Join hundreds of professionals using LegisGo to stay ahead of legislative changes.
Instant Alerts
Get notified when bills you track move through the legislature
AI Summaries
Understand complex legislation in seconds with AI-powered analysis
Full Access
All 132 legislators, committee schedules, and voting records